Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Regulation of Wnt/beta-catenin signaling by protein kinases.

Verheyen EM, Gottardi CJ.

Dev Dyn. 2010 Jan;239(1):34-44. doi: 10.1002/dvdy.22019. Review.

2.

[Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].

Liu Y, Zhang CG, Zhou CY.

Beijing Da Xue Xue Bao. 2010 Apr 18;42(2):238-42. Review. Chinese.

3.

Wnt/beta-catenin signaling: components, mechanisms, and diseases.

MacDonald BT, Tamai K, He X.

Dev Cell. 2009 Jul;17(1):9-26. doi: 10.1016/j.devcel.2009.06.016. Review.

4.

Wnt/beta-catenin signaling: new (and old) players and new insights.

Huang H, He X.

Curr Opin Cell Biol. 2008 Apr;20(2):119-25. doi: 10.1016/j.ceb.2008.01.009. Epub 2008 Mar 12. Review.

5.

The various roles of ubiquitin in Wnt pathway regulation.

Tauriello DV, Maurice MM.

Cell Cycle. 2010 Sep 15;9(18):3700-9. doi: 10.4161/cc.9.18.13204. Epub 2010 Sep 25. Review.

6.

Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease.

Kormish JD, Sinner D, Zorn AM.

Dev Dyn. 2010 Jan;239(1):56-68. doi: 10.1002/dvdy.22046. Review.

7.

Axin: a master scaffold for multiple signaling pathways.

Luo W, Lin SC.

Neurosignals. 2004 May-Jun;13(3):99-113. Review.

PMID:
15067197
8.

Toggling a conformational switch in Wnt/β-catenin signaling: regulation of Axin phosphorylation. The phosphorylation state of Axin controls its scaffold function in two Wnt pathway protein complexes.

Tacchelly-Benites O, Wang Z, Yang E, Lee E, Ahmed Y.

Bioessays. 2013 Dec;35(12):1063-70. doi: 10.1002/bies.201300101. Epub 2013 Sep 19. Review.

9.

FAK and WNT signaling: the meeting of two pathways in cancer and development.

Fonar Y, Frank D.

Anticancer Agents Med Chem. 2011 Sep;11(7):600-6. Review.

PMID:
21707509
10.

The Wnt/beta-catenin signaling pathway as a target in drug discovery.

Takahashi-Yanaga F, Sasaguri T.

J Pharmacol Sci. 2007 Aug;104(4):293-302. Review.

11.

MicroRNA roles in beta-catenin pathway.

Huang K, Zhang JX, Han L, You YP, Jiang T, Pu PY, Kang CS.

Mol Cancer. 2010 Sep 21;9:252. doi: 10.1186/1476-4598-9-252. Review.

12.

Wnt/beta-catenin signaling and cardiogenesis: timing does matter.

Tzahor E.

Dev Cell. 2007 Jul;13(1):10-3. Review.

13.

Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling.

Lien WH, Fuchs E.

Genes Dev. 2014 Jul 15;28(14):1517-32. doi: 10.1101/gad.244772.114. Review.

14.

The β-catenin destruction complex.

Stamos JL, Weis WI.

Cold Spring Harb Perspect Biol. 2013 Jan 1;5(1):a007898. doi: 10.1101/cshperspect.a007898. Review.

15.

A new look at TCF and beta-catenin through the lens of a divergent C. elegans Wnt pathway.

Phillips BT, Kimble J.

Dev Cell. 2009 Jul;17(1):27-34. doi: 10.1016/j.devcel.2009.07.002. Review.

16.

Convergence between Wnt-β-catenin and EGFR signaling in cancer.

Hu T, Li C.

Mol Cancer. 2010 Sep 9;9:236. doi: 10.1186/1476-4598-9-236. Review.

17.

The Wnt/beta-catenin pathway in adrenocortical development and cancer.

El Wakil A, Lalli E.

Mol Cell Endocrinol. 2011 Jan 30;332(1-2):32-7. doi: 10.1016/j.mce.2010.11.014. Epub 2010 Nov 20. Review.

PMID:
21094679
18.

Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.

Ying Y, Tao Q.

Epigenetics. 2009 Jul 1;4(5):307-12. Epub 2009 Jul 25. Review.

PMID:
19633433
19.

Wnt/Β-catenin and sex hormone signaling in endometrial homeostasis and cancer.

Wang Y, van der Zee M, Fodde R, Blok LJ.

Oncotarget. 2010 Nov;1(7):674-84. Review.

20.

Cystic kidney disease: the role of Wnt signaling.

Lancaster MA, Gleeson JG.

Trends Mol Med. 2010 Aug;16(8):349-60. doi: 10.1016/j.molmed.2010.05.004. Epub 2010 Jun 22. Review.

Supplemental Content

Support Center